Progesterone altering drug could reduce risk of aggressive breast cancer

17 June 2022

New research found that existing drugs that modify the effect of the hormone progesterone could reduce the risk of aggressive ‘triple negative’ breast cancer in women by altering the BRCA1 gene. Lead author Professor Martin Widschwendter (UCL EGA Institute for Women’s Health).